# Gain Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2026

- Company: [Gain Therapeutics, Inc.](/companies/ganx.md) (CIK 1819411)
- Form: DEF 14A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 16:45 ET
- Period: 2026-06-24
- Accession: 0001104659-26-050431
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819411/000110465926050431/ganx-20260624xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819411/000110465926050431/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819411/000110465926050431/ganx-20260624xdef14a.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-050431. Last ingested by Listed: Oct 30, 2026, 17:20 ET. No prices; not investment advice.